NEO · Neogenomics Inc
$15.94
-0.45 (-2.75%)
At close · Aug 14
Market Cap
$2.08B
Shares
130.21M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | 2026-08-07 | |
| 10-Q | 2026-07-28 | 2026-06-30 | |
| 8-K | 2026-07-28 | — | |
| 8-K/A | 2026-07-22 | 2026-07-20 | |
| 8-K | 2026-07-20 | — | |
| 8-K | 2026-06-25 | 2026-06-23 | |
| 8-K | 2026-06-22 | 2026-06-16 | |
| 8-K | 2026-06-17 | — | |
| 8-K | 2026-06-15 | — | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-05-22 | 2026-05-21 | |
| 10-Q | 2026-04-28 | 2026-03-31 | |
| 8-K | 2026-04-28 | — | |
| DEF 14A | 2026-04-06 | 2025-12-31 | |
| 8-K | 2026-02-17 | — | |
| 10-K | 2026-02-17 | 2025-12-31 | |
| 8-K | 2026-01-12 | 2026-01-09 | |
| 8-K | 2025-12-30 | 2025-12-23 | |
| 8-K | 2025-10-28 | — | |
| 10-Q | 2025-10-28 | 2025-09-30 | |
| 8-K | 2025-08-08 | 2025-08-05 | |
| 8-K | 2025-07-29 | — | |
| 10-Q | 2025-07-29 | 2025-06-30 | |
| 8-K | 2025-06-24 | 2025-06-19 | |
| 8-K | 2025-05-27 | 2025-05-22 | |
| 8-K | 2025-04-29 | — | |
| 10-Q | 2025-04-29 | 2025-03-31 | |
| 8-K | 2025-04-08 | 2025-04-04 | |
| DEF 14A | 2025-04-08 | 2024-12-31 | |
| 8-K/A | 2025-03-31 | 2025-01-03 | |
| 8-K/A | 2025-03-19 | 2025-03-18 | |
| 8-K | 2025-03-18 | — | |
| 10-K | 2025-02-18 | 2024-12-31 | |
| 8-K | 2025-02-18 | — | |
| 8-K | 2025-01-15 | 2025-01-14 | |
| 8-K | 2025-01-10 | 2025-01-03 | |
| 8-K | 2024-11-05 | 2024-11-01 | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 10-Q | 2024-07-30 | 2024-06-30 | |
| 8-K | 2024-07-29 | — | |
| 8-K | 2024-05-24 | 2024-05-23 | |
| 8-K | 2024-04-30 | — | |
| 10-Q | 2024-04-30 | 2024-03-31 | |
| 8-K | 2024-04-18 | 2024-04-15 | |
| DEF 14A | 2024-04-08 | 2023-12-31 | |
| 8-K/A | 2024-02-26 | 2024-02-16 | |
| 8-K | 2024-02-23 | 2024-02-16 | |
| 8-K | 2024-02-20 | — | |
| 10-K | 2024-02-20 | 2023-12-31 | |
| 8-K | 2023-11-06 | — |
Showing 1–50 of 141 filings
Key facts
CIK
1077183
CUSIP
64049M209
13F (30d)
250 filings
248 filers
Visit website
Investor relations